Maintenance of Early Improvement on the Symbol Digit Modalities Test Associated with Long-Term Ozanimod Use: Final Analysis from the Phase 3 SUNBEAM and DAYBREAK Extension Trials

Category Primary study
ConferenceThe 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Year 2024
This article has no abstract
Epistemonikos ID: 49df6a01d2520a43f982afaaeca01ac1c591d49a
First added on: Apr 04, 2026